Literature DB >> 9487800

p53 Mutations in hairless SKH-hr1 mouse skin tumors induced by a solar simulator.

H N Ananthaswamy1, A Fourtanier, R L Evans, S Tison, C Medaisko, S E Ullrich, M L Kripke.   

Abstract

In this study, we investigated whether the spectrum of p53 mutations in skin tumors induced in hairless SKH-hr1 mice by a solar simulator (290-400 nm) are similar to those found in skin tumors induced in C3H mice by UV radiation from unfiltered (250-400 nm) and Kodacel-filtered (290-400 nm) FS40 sunlamps. Analysis of tumor DNA for p53 mutations revealed that 14 of 16 (87.5%) SkH-hr1 skin tumors induced by the solar simulator contained mutations. Single C-->T transitions at dipyrimidine sequences located on the nontranscribed DNA strand were the most predominant type of p53 mutation. Remarkably, 52% of all p53 mutations in solar simulator-induced SKH-hr1 skin tumors occurred at codon 270, which is also a hotspot in C3H skin tumors induced by unfiltered and Kodacel-filtered FS40 sunlamps. However, T-->G transversions, which are hallmarks of UVA-induced mutations, were not detected in any of the solar simulator-induced skin tumors analyzed. These results demonstrate that the p53 mutation spectra seen in solar simulator-induced SKH-hr1 skin tumors are similar to those present in -unfiltered and Kodacel-filtered FS40 sunlamp-induced C3H skin tumors. In addition, our data indicate that the UVA present in solar simulator radiation does not play a role in the induction of p53 mutations that contribute to skin cancer development.

Entities:  

Mesh:

Year:  1998        PMID: 9487800     DOI: 10.1562/0031-8655(1998)067<0227:mihshm>2.3.co;2

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  8 in total

Review 1.  p53 and the pathogenesis of skin cancer.

Authors:  Cara L Benjamin; Honnavara N Ananthaswamy
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-15       Impact factor: 4.219

2.  Acceleration of 5-methylcytosine deamination in cyclobutane dimers by G and its implications for UV-induced C-to-T mutation hotspots.

Authors:  Vincent J Cannistraro; John-Stephen Taylor
Journal:  J Mol Biol       Date:  2009-07-22       Impact factor: 5.469

3.  [Socio-legal evaluation of UV-induced skin tumors].

Authors:  S Völter-Mahlknecht; M Berneburg; D-M Rose; H Drexler; M Röcken; S Letzel; W Wehrmann
Journal:  Hautarzt       Date:  2005-08       Impact factor: 0.751

4.  UVA-induced cyclobutane pyrimidine dimers form predominantly at thymine-thymine dipyrimidines and correlate with the mutation spectrum in rodent cells.

Authors:  Patrick J Rochette; Jean-Philippe Therrien; Régen Drouin; Daniel Perdiz; Nathalie Bastien; Elliot A Drobetsky; Evelyne Sage
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

5.  Rapid repair of UVA-induced oxidized purines and persistence of UVB-induced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells.

Authors:  Ahmad Besaratinia; Sang-In Kim; Gerd P Pfeifer
Journal:  FASEB J       Date:  2008-03-07       Impact factor: 5.191

6.  Methyl CpG binding protein 2 (MeCP2) enhances photodimer formation at methyl-CpG sites but suppresses dimer deamination.

Authors:  Vincent J Cannistraro; John-Stephen A Taylor
Journal:  Nucleic Acids Res       Date:  2010-07-02       Impact factor: 16.971

7.  Loss of retinoic acid receptor-related receptor alpha (Rorα) promotes the progression of UV-induced cSCC.

Authors:  Guolong Zhang; Guorong Yan; Zhiliang Fu; Yuhao Wu; Fei Wu; Zhe Zheng; Shan Fang; Ying Gao; Xunxia Bao; Yeqiang Liu; Xiuli Wang; Sibo Zhu
Journal:  Cell Death Dis       Date:  2021-03-04       Impact factor: 8.469

8.  Integrative transcriptomic analysis for linking acute stress responses to squamous cell carcinoma development.

Authors:  Tran N Nguyen; Kimal Rajapakshe; Courtney Nicholas; Leticia Tordesillas; Erik A Ehli; Christel M Davis; Cristian Coarfa; Elsa R Flores; Sally E Dickinson; Clara Curiel-Lewandrowski; Kenneth Y Tsai
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.